SomnoMed Limited

SOMNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$3,351-$106-$5,895-$6,347
Dep. & Amort.$2,808$2,933$3,902$2,903
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,331$616-$448$525
Change in WC-$4,231$0-$2,985$0
Other Non-Cash$7,150$634$3,667-$1,655
Operating Cash Flow$3,707$4,076-$1,759-$4,574
Investing Activities
PP&E Inv.-$1,775-$646-$862-$2,207
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$819-$737-$2,271$0
Investing Cash Flow-$2,594-$1,383-$3,134-$2,207
Financing Activities
Debt Repay.$0-$1,480$0-$6,333
Stock Issued$0$0$21,430$14,573
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,860$0$8,438$14,573
Financing Cash Flow-$1,860-$1,525$8,438$8,241
Forex Effect-$458$1,151-$204-$578
Net Chg. in Cash-$18,498$18,498$3,341$881
Supplemental Information
Beg. Cash$18,498$0$12,838$11,956
End Cash$0$18,498$16,179$12,838
Free Cash Flow$1,932$3,430-$2,621-$6,782